Amerise Biosciences Share Price
Small Cap | Pharmaceuticals and health care | BSE: 531681
₹0.94 
-0.04 (-4.08 %)
Last Updated: 11 Feb 2025 03:41 PM
BEARISH
Overview
Open (₹) 0.99
High (₹) 0.99
Low (₹) 0.94
Prev. Close (₹) 0.98
Volume 2,06,079
VWAP (₹) 0.99
ROCE (%) -2.71
Industry P/E 47.86
TTM P/E -94.00
P/B Ratio 1.16
Market Cap (₹) Cr.6.21
Dividend Yield (%)--
EPS (₹) -0.02
ROE-2.47%
Sales Growth (%) --
Profit Growth (%)22.88
Day Range
0.990.99
52 Week Range
0.551.45
Historical Returns
Returns (6M)
36.23 %
Returns (1Y)
23.68 %
Returns (3Y)
-52.28 %
Returns (5Y)
14.63 %
Returns (6M)
36.23 %
Returns (1Y)
23.68 %
Returns (3Y)
-52.28 %
Returns (5Y)
14.63 %
SWOT Analysis
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
Technicals
Technical Rating
BEARISHRSI 38.36
MFI 20.29
ATR 0.06
Commodity Channel Index -60.98
ROC125 47.06
ROC21 -15.97
Williams %R -73.68
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 1 | 1.01 | 1.02 | 0.99 | 0.98 | 0.97 | 0.96 |
| Week Ago | 1.04 | 1.07 | 1.11 | 1 | 0.97 | 0.93 | 0.9 |
| Month Ago | 1.18 | 1.21 | 1.25 | 1.14 | 1.11 | 1.07 | 1.04 |
EMA & SMA
0.94
Current Price
Bullish Moving Averages
2
Bearish Moving Averages
18
5 Day 0.99
9 Day 1
10 Day 1
12 Day 1
14 Day 1.01
20 Day 1.05
26 Day 1.08
50 Day 1.13
100 Day 1.02
200 Day 0.85
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| DIPAKKUMARGAUTAM | bulk | Sell | 08 Jan, 2025 | ₹1.19 | 3,80,933 | BSE |
| SARDAR SINGH RANWA | bulk | Buy | 12 Nov, 2024 | ₹1.05 | 3,67,619 | BSE |
| SULEKHA RANI | bulk | Sell | 03 Jul, 2023 | ₹0.75 | 4,13,202 | BSE |
| SULEKHA RANI | bulk | Buy | 03 Jul, 2023 | ₹0.74 | 108 | BSE |
| NAKUL HASMUKH AMIN | bulk | Buy | 27 Sept, 2022 | ₹1.02 | 4,25,726 | BSE |
| NAKUL HASMUKH AMIN | bulk | Sell | 21 Sept, 2022 | ₹0.99 | 4,50,000 | BSE |
| SUNEELKUMARBABULALMEENA | bulk | Buy | 25 Aug, 2022 | ₹1.15 | 4,00,000 | BSE |
| NAKUL HASMUKH AMIN | bulk | Buy | 24 Aug, 2022 | ₹1.01 | 7,50,000 | BSE |
| BALAMURUGAN V | bulk | Sell | 08 Aug, 2022 | ₹0.96 | 4,20,059 | BSE |
| NAKUL HASMUKH AMIN | bulk | Sell | 13 Jul, 2022 | ₹0.94 | 3,64,771 | BSE |
Insider Trading
Corporate Actions
No corporate actions available.
Announcements
| Date | Source | Detail |
|---|---|---|
| 04 Feb, 2025 | BSE India | UPDATION PURSUANT TO REG 30(6) OF SEBI LODR 2015 FOR LETTER FILED EARLIER DATED 03.02.2025 |
| 03 Feb, 2025 | BSE India | PFA |
| 03 Feb, 2025 | BSE India | PFA |
| 03 Feb, 2025 | BSE India | Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Monday 3rd February 2025 at the Registered Office of the Company and transacted the following major businesses: \r\n\r\n1.) Considered and approved Un-audited financial results for the quarter and nine months ended on 31st December 2024.\r\n\r\n2.) The board has considered and accepted the resignation of Independent Director Mr Niraj Vaghela w e.f 03.02.2025.\r\n\r\n3.) Mr. Kelash Bunkar is appointed as non-executive independent director of the company \r\nw e f. 03.02.2025 subject to approval of members in AGM.\r\n \r\n \r\nThe board meeting commenced at 05:40 PM and concluded at 06:00 PM\r\n\r\nPlease take the above intimation in your records.\r\n\r\n |
| 22 Jan, 2025 | BSE India | Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2025 ,inter alia, to consider and approve Pursuantto Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,\r\nwe would like to inform you that a meeting of the Board of Directors of the Company will be held on\r\nMonday 3rd February 2025 inter alia, to consider following business. -\r\n1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter ended\r\non 31st December 2024.\r\n2.) To approve and consider the appointment of Mr. Kelash Bunkar as Director of the Company.\r\n3.) To consider the resignation of Mr. Niraj Vaghela from directorship of the Company.\r\n4.) Any other matter with the permission of the board which the Board may think fit.\r\n\r\nPlease take the above intimation in your records.\r\nThanking You.\r\n |
| 23 Oct, 2024 | BSE India | PFA |
| 22 Oct, 2024 | BSE India | PFA |
| 22 Oct, 2024 | BSE India | Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Tuesday 22th October 2024 at the Registered Office of the Company and transacted the following major businesses: \r\n\r\n1.) Considered and approved Un-audited financial results for the quarter ended as on 30th September, 2024.\r\n\r\nThe board meeting commented at 01.30 PM and concluded at 02.05 PM\r\n\r\n\r\n |
| 15 Oct, 2024 | BSE India | Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/10/2024 ,inter alia, to consider and approve PFA |
| 07 Oct, 2024 | BSE India | PFA |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results & Others | Inter-alia, to consider 1. Appointment of Mr. Kelash Bunkar as Director of the Company. 2. Resignation of Mr. Niraj Vaghela from directorship of the company. 3.Other business matters. | 23 Jan, 2025 | 03 Feb, 2025 |
| Quarterly Results | -- | 16 Oct, 2024 | 22 Oct, 2024 |
| Quarterly Results | -- | 31 Jul, 2024 | 06 Aug, 2024 |
| Audited Results | -- | 20 May, 2024 | 23 May, 2024 |
| Quarterly Results | -- | 17 Jan, 2024 | 22 Jan, 2024 |
| Quarterly Results | -- | 27 Oct, 2023 | 07 Nov, 2023 |
| Quarterly Results | -- | 07 Aug, 2023 | 08 Aug, 2023 |
| Audited Results | -- | 28 Apr, 2023 | 04 May, 2023 |
| Quarterly Results | -- | 19 Jan, 2023 | 25 Jan, 2023 |
| Quarterly Results | -- | 07 Nov, 2022 | 12 Nov, 2022 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Amerise Biosciences
Amerise Biosciences is a Public Limited Listed company incorporated on 27/08/1984 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L29199GJ1984PLC007195 and registration number is 007195. Currently company belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 6.61 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1984
Managing Director
-- --
NSE Symbol
--
Amerise Biosciences Management
| Name | Designation |
|---|---|
| Mr. Dineshkumar Tribhovanbhai Rathod | WholeTime Director & CFO |
| Ms. Manisha Maneklal Patel | Director |
| Mr. Niraj Vaghela | Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| SunPhrmInds | ₹4,46,576.22 | ₹1,701.60  ₹1,732.10(-1.76%) | ₹1,249.800 - ₹1,960.200 |
| Divis Labora | ₹1,56,123.40 | ₹5,940.00  ₹5,938.80(0.02%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,21,675.13 | ₹1,447.00 ₹1,458.85(-0.81%) | ₹1,240.700 - ₹1,702.000 |
| ManKind Phar | ₹1,18,478.90 | ₹2,455.00 ₹2,502.05(-1.88%) | ₹1,910.100 - ₹3,050.000 |
| DrReddysLab | ₹1,15,939.04 | ₹1,214.90 ₹1,220.95(-0.50%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Amerise Biosciences
What is the share price of Amerise Biosciences?
The share price of Amerise Biosciences on 11 Feb, 2025 is ₹ 0.94.
What is 52W high and 52W low share price of Amerise Biosciences?
The highest and lowest 52W share prices of Amerise Biosciences are ₹ 1.450 and ₹ 0.550
What is the market cap of Amerise Biosciences?
The market capitalization of Amerise Biosciences as of 11 Feb, 2025 is ₹ 6.21 Crores
What is the P/E ratio of Amerise Biosciences?
The current P/E ratio of Amerise Biosciences as of 11 Feb, 2025 is 47.86
What is the PB ratio of Amerise Biosciences?
The PB ratio of Amerise Biosciences as of 11 Feb, 2025 is 1.16
Top Gainers
948IHFL26I
IBHFL NCD186
₹845
₹705 (0.2%)
GREAVESCOT
Greaves
₹281.85
₹234.9 (0.2%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.2%)
CAPRO
Caprola.Chem
₹62.4
₹52 (0.2%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.1%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.1%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0%)